Zephex® Discusses Future of pMDI Propellants at RDD Europe 2017

Zephex®, Mexichem’s leading brand of HFA medical propellants, will be exhibiting at RDD Europe in Nice, France from 25th to 28th April.

Mexichem is committed to meeting the future requirements of pMDI customers and development work continues on new solutions to meet these needs. Our Zephex® industry experts will be available to discuss their work and how it benefits customers.

This includes new products targeted to maintain the excellent performance of the current Zephex® range and meet future demands of the pharmaceutical industry, including those arising from environmental legislation such as the recent Kigali Amendment to the Montreal Protocol.

The team can also discuss Mexichem’s ongoing program of investment in the Zephex® business, including substantial increases in package and isotank numbers and establishing new regional operational centres to deliver the highest levels of service and increased ability to respond to customer needs.

Back to News